• <input id="ycg2u"></input>
    <legend id="ycg2u"></legend>
    <strong id="ycg2u"><u id="ycg2u"></u></strong>
  • Enable Accessibility Enable Accessibility

    Project members

    We are committed to providing innovative treatments to patients through iPS cell technology.

    At T-CiRA, several novel research projects focusing on the creation of medical applications of iPSC are underway, led by nine principal investigators (PI) with Co-principal investigators (Co-PI) from Takeda.


     

    Cell Therapy

    Group 353.png

    Development of a novel immunotherapy using iPSC-derived immune cells

    Shin Kaneko(PI, CiRA)
    Akira Hayashi(Co-PI, Takeda)
    Yoshiaki Kassai(Co-PI, Takeda)
    Shoichi Iriguchi(Sub PI, CiRA)
    Keiko Koga(Sub PI, Takeda)

    Group 355.png

    Research on Cell Therapy against Type 1 Diabetes

    Taro Toyoda (PI, CiRA)
    Ryo Ito(Co-PI, Takeda)
    Shuhei Konagaya(Sub PI, CiRA)
    Yutaka Tanoue(Sub PI, Takeda)
    Hikaru Ueno(Sub PI, Takeda)
    Noriko Yamazoe(SubPI, Takeda)

    Group 357.png

    Development of an iPSC-derived cardiomyocyte cell therapy for severe heart failure

    Yoshinori Yoshida (PI, CiRA)
    Tomoyuki Nishimoto (Co-PI, Takeda)
    Norihisa Tamura(Sub PI, Takeda)
    Yasuharu Kamachi(Sub PI, Takeda)





    創薬

    Group 359.png

    ALS/ASD drug discovery and development using patient derived iPSCs

    Haruhisa Inoue (PI, CiRA)
    Hiroshi Yukitake (Co-PI, Takeda)
    Inigo Narvaiza(Sub PI, Takeda)
    Keisuke Shibata(Sub PI, Takeda)

    Group 361.png

    Drug discovery for intractable muscular disease using patient-derived iPSCs

    Hidetoshi Sakurai (PI, CiRA)
    Ryuichi Tozawa (Co-PI, Takeda)
    Tomoya Uchimura(Sub PI, CiRA)
    Masahiro OKa(Sub PI, Takeda)
    Tatsuo Oikawa(Sub PI, Takeda)



    Group 363.png

    Development of therapeutic agents for rare hereditary diseases using iPS cells

    Tadashi Suzuki (PI, RIKEN)
    Ryuichi Tozawa(Co-PI, Takeda)
    Hiroto Hirayama(Sub PI, RIKEN)
    Takayuki Kamei(Sub PI, Takeda)

    Living with NGLY1 deficiency: Grace’s Story

    Group 364.png

    Drug discovery for genetic cardiac disease using a novel iPSC-based platform

    Yoshinori Yoshida(PI, CiRA)
    Tomoyuki Nishimoto(Co-PI, Takeda)
    Kenichi Imahashi(Co-PI, Takeda)
    Misato KoakutsuSub PI, CiRA
    Kohei DeguchiSub PI, Takeda





    Platform Technology

    Group 366.png

    A new research platform with human iPSC-derived neural crest cells and its applications for drug discovery and regenerative medicine

    Makoto Ikeya (PI, CiRA)
    Hirokazu Matsumoto (Co PI, Takeda)
    Daisuke Kamiya (Sub PI, CiRA)
    Yayoi Toyooka (Sub PI, CiRA)
    Kazumi Take (Sub PI, Takeda)
    Teruyoshi Yamashita (Sub PI, Takeda)

    Group 370.png

    Development of novel gene therapy for Duchenne muscular dystrophy, by using genome editing and delivery technologies

    Akitsu Hotta (PI, CiRA)
    Naoto Inukai (Co-PI, Takeda)
    Eriya Kenjo(Sub PI, Takeda)
    Hiroyuki Hozumi(Sub PI, Takeda)

    ?Recruiting (CiRA) 



    プロジェクト詳細


    button_pdf_E.png

    国产AV网站_中午文字幕av一区二区三区_性进入裸体视频_久久久久久精品免费免费直播